IFITM1 and colorectal cancer: Transfection of LoVo and HT-29 colorectal cancer cells with small interfering RNA (siRNA) targeting IFITM1 reduced migration and invasion capacities of these cells in a wound-healing assay, whereas overexpression of IFITM1 enhanced these capacities (44).